Healthtech Startups

99 Technologies develops automated room and targeted surface disinfection systems for healthcare facilities and public environments to prevent healthcare-acquired infections. The company offers integrated disinfection technologies designed for clinical settings and public spaces.

1 investor

9amHealth provides virtual cardiometabolic care covering weight management, diabetes, and heart health, combining prescription medication (including GLP-1s when needed) with lifestyle changes. Its care team of obesity specialists, pharmacists, dietitians, and behavioral health experts delivers telemedicine treatment plans and ships medication to members.

1 investor

9lione is a cloud-based pharmaceutical inventory management system that lets pharmacies scan prescriptions via OCR (including handwritten ones) and read GS-1 codes to automate stock tracking, ordering, and demand forecasting. It targets pharmacists and healthcare providers, and includes features for managing lending/borrowing of drugs between nearby pharmacies.

1 investor

9Solutions provides indoor location-based safety, communications, and smart care solutions for healthcare facilities to support safe and high-quality care delivery.

1 investor

A mobile platform where users can ask questions on any topic and receive answers from verified professionals such as doctors, lawyers, and accountants. The service creates personalized feeds based on user interests and facilitates community discussion around expert knowledge.

1 investor

A Place for Mom is a senior care referral service that helps families find and compare senior living and care options, including assisted living, memory care, independent living, home care, nursing homes, and senior apartments. It also provides guides and resources such as VA benefits information for long-term care.

1 investor

A-Champs develops Cognitive-Motor Training hardware and software for athletes, coaches, and therapists to improve reactive intelligence and decision-making under pressure. The company offers ROX, a multi-sensory reaction training system combining lights, sound, and vibration cues with app-based tracking, used across sports training, neuro-athletic development, and rehabilitation.

1 investor

A-LIST offers personalized digital health treatments and supplements including NAD+, glutathione, weight management, and ED treatments, alongside AI-guided supplement recommendations and genetic testing through an online provider network.

1 investor

A2 Biotherapeutics develops cell therapy technology using the Tmod platform, which applies quantitative drug discovery methods to treat cancer patients.

1 investor

aabo manufactures AI-powered smart rings that track health metrics including heart rate, sleep, stress, and activity 24/7 for consumers seeking preventive health monitoring. The device combines optical sensors with proprietary algorithms to deliver actionable wellness insights without requiring a subscription.

1 investor

The American Academy of Child and Adolescent Psychiatry (AACAP) is a professional medical organization focused on child and adolescent mental health, publishing resources and policy statements on topics such as youth suicide, screen media use, autism spectrum disorders, and access to care. It provides guidance for families, clinicians, and policymakers on pediatric psychiatric issues.

1 investor

AADAR produces Ayurvedic herbal wellness supplements designed for men to enhance stamina, energy, and sexual performance. The company formulates natural supplements using traditional Ayurvedic ingredients such as Safed Musli, Ashwagandha, and Shilajit.

1 investor

Aakha Bio develops multi-specific antibodies for solid tumors that block disease pathways and activate immune cells. The company targets cancer patients with limited treatment options using a platform approach that integrates multiple therapeutic mechanisms into single molecules.

1 investor

AAVAA builds hands-free, voice-free assistive technology using brain-computer interface (BCI) and bio-sensors that translate head movements, blinks, and facial gestures into device commands. Its products, such as a Head-Mouse, let users control smart devices across platforms without external switches, aimed at accessible control for people needing assistive technology.

1 investor

Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer. The company serves cancer patients and is located in Germany, operating in the biotech sector.

1 investor

Abarca Health is a pharmacy benefit manager (PBM) that delivers cost savings, transparency, and flexibility to payers and employers through advanced technology and specialty pharmacy services. The company serves commercial health plans and government programs, with over 9 million members.

1 investor

Abartys Health provides a centralized healthcare data hub for managing medical records across providers, patients, and administrators. Operating in Latin America and the United States, the platform serves doctors, hospitals, labs, and other healthcare providers seeking secure, interoperable data management solutions.

1 investor

ABB Optical Group is the leading distributor of contact lenses, specialty vision products, and related services to eye care professionals across the United States. The company supplies products to nearly two-thirds of U.S. eye care providers and operates its own manufacturing and technology platforms to enhance practice operations and profitability.

1 investor

GOGOTECH develops ABBY, a hybrid manual/power-assist/electric "smart" wheelchair with a smart controller, machine vision (cameras and sensors), and IoT cloud connectivity, priced below $4,000. The company plans to sell directly to consumers as a personal electric vehicle and, pending FDA 510(k) clearance, as a Class II medical device through B2B distributors, targeting both developed and developing markets.

1 investor

Abby Health provides telehealth and primary care services for Australians, focusing on continuity of care by maintaining patient histories and enabling consistent doctor-patient relationships. The platform aims to address rural healthcare access gaps and system fragmentation through a patient-first digital health model.

1 investor

Supplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.

1 investor

AbelZeta develops T cell immunotherapies, advancing pipeline drug candidates through early-stage and investigator-initiated clinical trials to treat cancer and immune and inflammatory (I&I) diseases. The company runs an in-house platform for cell therapy development and partners with global pharmaceutical firms for clinical development and commercialization.

1 investor

Abeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases with high unmet need, including its approved product ZEVASKYN and its lead PSMA-targeted T cell therapy ABO-701 for advanced prostate cancer. It uses ex vivo gene therapy, viral vector, and synthetic immune receptor T cell (SIR-T) technologies to serve patients with genetic diseases and solid tumors.

1 investor

Ability is a biotechnology company developing highly-selective, immune cell-modulating antibody therapeutics for patients with inflammatory diseases and cancer. Its AbiLeap discovery engine uses AI and a database of antibody sequences to generate fully-human monospecific and bispecific antibodies, with a lead program targeting inflammatory skin diseases and other candidates for solid tumors.

1 investor